Primary Health Prop PLC (PHP)
Johannesburg Exchange · South Africa · prices in ZAR · close of 22 Oct 2026
Key indicators
| Last close | ZAR 1,960.00 |
|---|---|
| 52-week range | 1,916.00 – 2,517.00 |
| Return, 1 month / 3 months | −1.0% / −3.3% |
| Return, 1 year / 3 years | −3.1% / – |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 55.6% |
| Worst drawdown (1 year) | -22.8% |
| Average daily value traded | 661.66M ZAR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Primary Health Properties owns and manages healthcare buildings, chiefly doctors' surgeries and medical centres, which it leases to general practitioners and other healthcare providers. Its customers are mainly public and private healthcare operators, and its properties are concentrated in the United Kingdom and Ireland. The company is structured as a real estate investment trust and is based in the United Kingdom, where it derives most of its rental income from healthcare premises.
On this site Primary Health Prop PLC appears as a stock on the Johannesburg Exchange (South Africa), code PHP, with prices in South African rand (ZAR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Primary Health Prop PLC (PHP) trades on the Johannesburg Exchange in South Africa. It last closed at ZAR 1,960.00 on 22 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 145 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.1% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.8% | ||
| From 52-week high | -21.6% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.3% | ||
| 6-month return | -3.9% | ||
| 12-month return, skipping the last month | -2.2% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.8% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 661.66M ZAR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | −1.0% |
| 3 months | −3.3% |
| 6 months | −3.9% |
| 1 year | −3.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,986.92 / 2,037.85 |
|---|---|
| Golden / death cross (60 days) | Death, 17 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 42.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Oct 2026 | ZAC 40.0396 |
| 1 Jul 2026 | ZAC 40.0396 |
| 25 Mar 2026 | ZAC 40.0396 |
| 28 Jan 2026 | ZAC 40.0396 |
| 8 Oct 2025 | ZAC 38.9426 |
| 2 Jul 2025 | ZAC 38.9426 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.